Cargando…

Lipid Changes During Endocrine Therapy in Breast Cancer Patients: The Results of a 5-Year Real-World Retrospective Analysis

BACKGROUND: The aim of this study was to investigate the status of serum lipids during endocrine therapy. METHODS: We retrospectively analysed lipid profiles during the 5-year treatment of 1487 consecutive postoperative BC patients. Lipid parameters included triglycerides (TG), total cholesterol (TC...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Tao, Li, Xu, Li, Jiayuan, Wang, Zhu, Fan, Yuan, Li, Xiusong, Fu, Zhoukai, Wu, Yunhao, Lv, Qing, Luo, Ting, Zhong, Xiaorong, Chen, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801613/ https://www.ncbi.nlm.nih.gov/pubmed/35111662 http://dx.doi.org/10.3389/fonc.2021.670897

Ejemplares similares

Lipid changes during the perioperative period in patients with early breast cancer: a real-world retrospective analysis
por: He, Tao, et al.
Publicado: (2021)

Adjuvant chemotherapy-associated lipid changes in breast cancer patients: A real-word retrospective analysis
por: He, Tao, et al.
Publicado: (2020)

Pattern of Time-to-Surgery in Patients With Breast Cancer at Different Stages of the COVID-19 Pandemic
por: Chen, Ruixian, et al.
Publicado: (2022)

Real-World Data of Triplet Combination of Trastuzumab, Lapatinib, and Chemotherapy in HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Study
por: Li, Yi, et al.
Publicado: (2020)

Real-World Data on Apatinib Efficacy - Results of a Retrospective Study in Metastatic Breast Cancer Patients Pretreated With Multiline Treatment
por: Liu, Zhaoyun, et al.
Publicado: (2021)

Real-world experience with anti–programmed cell death protein 1 immunotherapy in patients with esophageal cancer: A retrospective single-center study
por: Wang, Xinpeng, et al.
Publicado: (2022)

Editorial: Real-world data and real-world evidence in hematologic malignancies
por: Malagola, Michele, et al.
Publicado: (2023)

Efficacy and Safety of Lenvatinib Combined With PD-1 Inhibitors Plus TACE for Unresectable Hepatocellular Carcinoma Patients in China Real-World
por: Li, Xiaowei, et al.
Publicado: (2022)

A Retrospective Analysis of the Effect of Irinotecan-Based Regimens in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes
por: Suo, Jiaojiao, et al.
Publicado: (2021)

Efficacy of intra-arterial chemotherapy with sequential anti-PD-1 antibody in unresectable gastric cancer: A retrospective real-world study
por: Xiang, Xiaosong, et al.
Publicado: (2023)

Efficacy evaluation of neoadjuvant chemotherapy in patients with HER2-low expression breast cancer: A real-world retrospective study
por: Tang, Lingfeng, et al.
Publicado: (2022)

The Effects of Endocrine Therapies on Lipid Profiles in Chinese Young Women With Early Breast Cancer
por: Kang, Yi-Kun, et al.
Publicado: (2021)

Chemotherapy Decision-Making and Survival Outcomes in Older Women With Early Triple-Negative Breast Cancer: Evidence From Real-World Practice
por: Xiu, Meng, et al.
Publicado: (2022)

Efficacy and safety of inetetamab-containing regimens in patients with HER2-positive metastatic breast cancer: a real-world retrospective study in China
por: Liu, Xiaoyu, et al.
Publicado: (2023)

Beyond Clinical Trials in Patients With Multiple Myeloma: A Critical Review of Real-World Results
por: Bertamini, Luca, et al.
Publicado: (2022)

The role of noncoding RNAs in cancer lipid metabolism
por: Wang, Ye, et al.
Publicado: (2022)

The efficacy and safety of epirubicin and cyclophosphamide combined with pyrotinib in neoadjuvant treatment for HER2-positive breast cancer: A real-world study
por: Li, Fu, et al.
Publicado: (2023)

Real-world survival of colon cancer after radical surgery: A single-institutional retrospective analysis
por: Pang, Xiangyi, et al.
Publicado: (2022)

Cisplatin-based chemotherapy for the treatment of metastatic collecting duct carcinomas: A real-world, retrospective analysis
por: Rizzo, Mimma, et al.
Publicado: (2022)

Safety and Efficacy of Immune Checkpoint Inhibitors for Patients With Metastatic Urothelial Carcinoma and End-Stage Renal Disease: Experiences From Real-World Practice
por: Kuo, Ming-Chun, et al.
Publicado: (2020)

Survival Benefits for Pulmonary Adenocarcinoma With Malignant Pleural Effusion After Thoracoscopic Surgical Treatment: A Real-World Study
por: Li, Xin, et al.
Publicado: (2022)

Real-World Data of Different Immune Checkpoint Inhibitors for Non-Small Cell Lung Cancer in China
por: Miao, Kang, et al.
Publicado: (2022)

Radiotherapy or chemotherapy: a real-world study of the first-time relapsed and refractory primary central nervous system lymphoma
por: Yang, Yu, et al.
Publicado: (2023)

Outcomes of Anlotinib Maintenance Therapy in Patients With Advanced NSCLC in a Real-World Setting
por: Li, Jia, et al.
Publicado: (2022)

What predicts the clinical benefits of PARP inhibitors in platinum-sensitive recurrent ovarian cancer: A real-world single-center retrospective cohort study from China
por: Zhang, Depu, et al.
Publicado: (2022)

Ovarian Real-World International Consortium (ORWIC): A multicentre, real-world analysis of epithelial ovarian cancer treatment and outcomes
por: Cheeseman, Sue, et al.
Publicado: (2023)

Clinical and genomic characterization of Chinese patients with functional high-risk multiple myeloma: A real-world validation study
por: Wang, Yu-tong, et al.
Publicado: (2023)

Real-World Practice of Hypofractionated Radiotherapy in Patients With Invasive Breast Cancer
por: Chen, Fang, et al.
Publicado: (2022)

PD-1 inhibitor versus bevacizumab in combination with platinum-based chemotherapy for first-line treatment of advanced lung adenocarcinoma: A retrospective-real world study
por: Huang, Zhe, et al.
Publicado: (2022)

Effectiveness of neoadjuvant immunochemotherapy compared to neoadjuvant chemotherapy in non-small cell lung cancer patients: Real-world data of a retrospective, dual-center study
por: Fei, Kailun, et al.
Publicado: (2023)

Predicting Lapatinib Dose Regimen Using Machine Learning and Deep Learning Techniques Based on a Real-World Study
por: Yu, Ze, et al.
Publicado: (2022)

Early detection of lung cancer in a real-world cohort via tumor-associated immune autoantibody and imaging combination
por: Liu, Zhong, et al.
Publicado: (2023)

Real-world outcomes of postmastectomy radiotherapy in breast cancer patients with 1–3 positive lymph nodes: a retrospective study
por: Chitapanarux, Imjai, et al.
Publicado: (2014)

A Real-World, Population-Based Retrospective Analysis of Therapeutic Survival for Recurrent Localized Renal Cell Carcinoma After Nephrectomy
por: Kim, Sung Han, et al.
Publicado: (2021)

Applying machine learning techniques to predict the risk of lung metastases from rectal cancer: a real-world retrospective study
por: Qiu, Binxu, et al.
Publicado: (2023)

Thromboembolic events in patients with paroxysmal nocturnal hemoglobinuria (PNH): Real world data of a Greek nationwide multicenter retrospective study
por: Chatzileontiadou, S., et al.
Publicado: (2023)

Editorial: Real World Outcomes of Lymphoma From India
por: Kumar, Lalit, et al.
Publicado: (2022)

Editorial: Real-World evidence in onco-hematological patients
por: Vener, Claudia, et al.
Publicado: (2022)

Rewiring of the Endocrine Network in Triple-Negative Breast Cancer
por: Li, Kaixuan, et al.
Publicado: (2022)

Multi-Modality Treatment for Patients With Metastatic Gastric Cancer: A Real-World Study in China
por: Zhao, Lin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gbas8p28gi44g6r1ib7k4rhc34